Fred Alger Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Fred Alger Management’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-43,677	Closed	-$1.48M	–	591
2021 Q2	$1.48M	Sell	43,677 -33,851	-44%	-$863K	﹤0.01%	365
2021 Q1	$1.81M	Buy	77,528 +31,717	+69%	+$961K	﹤0.01%	350
2020 Q4	$1.32M	Sell	45,811 -32,373	-41%	-$815K	﹤0.01%	353
2020 Q3	$1.58M	Buy	+78,184	New	+$1.91M	﹤0.01%	318

Fred Alger Management's CNST Position: Q3 2021 in Review

Fred Alger Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 43,677 shares — an estimated $1.48M sold.

Fred Alger Management first reported a position in CNST in Q3 2020 and held it in 4 quarters. The position peaked at $1.81M in Q1 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Fred Alger Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Fred Alger Management sold 43,677 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $1.48M.
Fred Alger Management first reported a position in Constellation Pharmaceuticals, Inc. in Q3 2020 and held it in 4 quarters.
Fred Alger Management's Constellation Pharmaceuticals, Inc. position peaked at $1.81M in Q1 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Fred Alger Management's 13F filing for Q3 2021, filed 15 Nov 2021.